This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Programme for Injectable Therapies for People with Type 2 Diabetes

January 2024 - 2025

To register your interest in PITstop contact your local representative, or use the form below to get in touch and find a representative in your area.

Registering does not guarantee a place on PITstop

Virtual Training Courses

An accredited virtual promotional training course held over 2.5 days that supports healthcare professionals who are managing people with Type 2 diabetes on more complex regimens, including GLP-1 and insulin initiation.

Programme summary

Expect a variety of different topics on devices, insulins and other injectable therapies including:

  • Revision of diabetes oral medications
  • GLP-1 agonists including initiation using a structured care pathway
  • Detective work at review appointments focusing on injectables
  • Insulin safety (self-directed learning)
  • Working through the PITstop insulin pathway to assess for insulin, initiate an appropriate insulin regimen and support the patient for the first 6 months: a case study approach
  • Dietary considerations and insulin, including minimising weight gain
  • Embedding the learning and university accreditation

Who is this course suitable for?

GPs, Nurse Practitioners, Practice Nurses, Clinical Pharmacists and Physician Associates (who are working as part of a practice diabetes team), already experienced in providing a diabetes service. Only HCPs who are patient facing and have the ability to initiate and prescribe injectables post the course should apply.

New to post DSNs identified as requiring training at this level, may also be suitable for this course.

Delegates must have completed a diabetes course to foundation level or be able to provide evidence of self-directed learning, focusing on the oral diabetes medication pathway.  Suitable courses include Pre-PITstop, Warwick Certificate in Diabetes or Bradford Diabetes Certificate. You will be required to evidence this within your application.

Delegates will be required to have a named mentor in place to support completion of the competency framework post the course.  Details of the mentor will be required at the application process.  New to PITstop mentors will be invited to complete a ½ day mentor workshop by PITstop.

Interested?

If you are interested in attending a course please contact your local representative, or use the form below to get in touch and find a representative in your area.

Delegates who do not meet the course suitability criteria will not be registered onto the programme or may be contacted for further information.  You will receive notification from Sanofi within 1 month once you have submitted your application confirming if you have been allocated a place on the course.

2024/25 Course Dates

Find below the dates for the 2 and a half day courses, starting in 2024.

Sohail Akhtar
23/08/24

This educational programme is organised and funded by Sanofi. The PITstop for Diabetes course content has been independently developed and will be delivered by PITstop for Diabetes on behalf of Sanofi. Sanofi have had no input or involvement in the creation of these materials but has reviewed the content to ensure compliance with the ABPI code of practice. Adverse event reporting and prescribing information is available at the meetings.

If you would like to contact us further to discuss your place please either reach out to your local representative or email us at SanofiPITstop@sanofi.com

Having undertaken many training courses, PITstop stands out as being pivotal in my learning, I would recommend it to other staff. I even occasionally still dig out the book!

Heidi Irons

Community Diabetes Specialist Nurse

Get in touch with the Diabetes Team

MAT-XU-2202113 (v10.0) Date of Preparation: September 2024